ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors ...Middle East

GHENT, Belgium, Nov. 3, 2020 /PRNewswire/ -- ExeVir, which is developing nanobody therapies providing broad protection against viral infections, including a lead candidate for coronaviruses, today announced that Michel Kazatchkine and Stef Heylen have been appointed to the Board. Both...

Hence then, the article about exevir bio appoints michel kazatchkine and stef heylen to the board of directors was published today ( Tuesday 03/11/2020 - 11:20 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors )

Also on site :

• Cyberattack hits Canvas system used by thousands of schools as finals loom
• Philadelphia Soccer 2026 otvára akreditácie médií a registráciu fanúšikov na festival fanúšikov FIFA Fan Festival™ vo Philadelphii
• China Innovative Drug NHWD-870 Receives Breakthrough Therapy Designation, Bringing New Hope of Survival to NUT Carcinoma Patients